Literature DB >> 24994495

Antibiotic susceptibility pattern of genital tract bacteria in pregnant women with preterm premature rupture of membranes in a resource-limited setting.

George U Eleje1, Joseph I Adinma2, Samuel Ghasi3, Joseph I Ikechebelu2, Anthony O Igwegbe2, John E Okonkwo2, Charles I Okafor2, Chukwuemeka O Ezeama2, Ifeanyichukwu U Ezebialu4, Chukwuanugo N Ogbuagu5.   

Abstract

OBJECTIVE: To identify microbes prevalent in the genital tract of pregnant women with preterm premature rupture of membranes (PPROM) and to assess the susceptibility of the microbial isolates to a range of antibiotics to determine appropriate antibiotics for treating cases of PPROM in resource-limited settings.
METHODS: A prospective cross-sectional study was undertaken involving women with (n=105) and without (n=105) a confirmed diagnosis of PPROM admitted to Nnamdi Azikiwe University Teaching Hospital, southeast Nigeria, between January 1, 2011, and April 30, 2013. Endocervical swabs were collected from all participants and examined microbiologically. Antibiotic sensitivity testing was performed using Kirby-Bauer disk diffusion.
RESULTS: Streptococcus spp., Staphylococcus aureus, and Escherichia coli were significantly more prevalent among women with PPROM than among those without PPROM (P<0.01). Among the antibiotics considered safe to use during pregnancy, the bacteria were most sensitive to ampicillin-sulbactam, cefixime, cefuroxime, and erythromycin.
CONCLUSION: For the first 48hours, women with PPROM should receive an intravenous dose combining ampicillin-sulbactam, cefixime, cefuroxime, or erythromycin with metronidazole followed by oral administration of the chosen antibiotic combination to complete a 7-day course.
Copyright © 2014 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aerobic cervical bacteriology; Antibiotic sensitivity testing; Antibiotic susceptibility; Female genital tract; Microbiology; Pregnant women; Preterm premature rupture of membranes (PPROM)

Mesh:

Substances:

Year:  2014        PMID: 24994495     DOI: 10.1016/j.ijgo.2014.04.016

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  6 in total

Review 1.  A systematic review and meta-analysis on the prevalence of Escherichia coli and extended-spectrum β-lactamase-producing Escherichia coli in pregnant women.

Authors:  Yousef Moradi; Babak Eshrati; Seyed Abbas Motevalian; Ali Majidpour; Hamid Reza Baradaran
Journal:  Arch Gynecol Obstet       Date:  2021-01-02       Impact factor: 2.344

2.  Performance indices of AmnioQuick Duo+ versus placental α-microglobulin-1 tests for women with prolonged premature rupture of membranes.

Authors:  George U Eleje; Euzebus C Ezugwu; Ifeanyichukwu U Ezebialu; Nnabuike O Ojiegbe; Richard O Egeonu; Chukwudi C Obiora; Chigozie G Okafor; Joseph I Ikechebelu; Ahizechukwu C Eke
Journal:  Int J Gynaecol Obstet       Date:  2018-11-20       Impact factor: 4.447

3.  Effects of histone H4 hyperacetylation on inhibiting MMP2 and MMP9 in human amniotic epithelial cells and in premature rupture of fetal membranes.

Authors:  Zhihui Song; Lili Yang; Wei Hu; Jianping Yi; Fumin Feng; Lingyan Zhu
Journal:  Exp Ther Med       Date:  2021-03-22       Impact factor: 2.447

4.  Staphylococcus aureus Infection of Human Gestational Membranes Induces Bacterial Biofilm Formation and Host Production of Cytokines.

Authors:  Ryan S Doster; Leslie A Kirk; Lauren M Tetz; Lisa M Rogers; David M Aronoff; Jennifer A Gaddy
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

5.  Cervical stitch (cerclage) in combination with other treatments for preventing spontaneous preterm birth in singleton pregnancies.

Authors:  George U Eleje; Ahizechukwu C Eke; Joseph I Ikechebelu; Ifeanyichukwu U Ezebialu; Princeston C Okam; Chito P Ilika
Journal:  Cochrane Database Syst Rev       Date:  2020-09-24

6.  Antimicrobial resistance in Africa: a systematic review.

Authors:  Birkneh Tilahun Tadesse; Elizabeth A Ashley; Stefano Ongarello; Joshua Havumaki; Miranga Wijegoonewardena; Iveth J González; Sabine Dittrich
Journal:  BMC Infect Dis       Date:  2017-09-11       Impact factor: 3.667

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.